Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hypertension

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 96 articles:
HTML format



Single Articles


    March 2024
  1. PETER JG, Ntusi NAB, Ntsekhe M
    Are Recommendations That Favor Other Agents Over Angiotensin-Converting Enzyme Inhibitors in Africans With Hypertension Justified?
    Circulation. 2024;149:804-806.
    PubMed    


  2. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
    Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
    PubMed     Abstract available


    February 2024
  3. REDING KW, Jordan JH
    Multimodal Imaging Evidence for Optimized Blood Pressure Control Following Hypertensive Pregnancy: Mechanistic Insights Into Beneficial Cardiac Remodeling From the POP-HT Trial.
    Circulation. 2024;149:542-544.
    PubMed    


  4. PITT B, Williams GH
    Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators?
    Circulation. 2024;149:414-416.
    PubMed    


  5. LUO Y, Qi X, Zhang Z, Zhang J, et al
    Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension.
    Circulation. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.067579.
    PubMed     Abstract available


    January 2024
  6. BIAN JS, Chen J, Zhang J, Tan J, et al
    ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.
    Circulation. 2024 Jan 12. doi: 10.1161/CIRCULATIONAHA.123.067005.
    PubMed     Abstract available


    December 2023
  7. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    PubMed     Abstract available


  8. REAY WR, Clarke E, Eslick S, Riveros C, et al
    Using Genetics to Inform Interventions Related to Sodium and Potassium in Hypertension.
    Circulation. 2023 Dec 22. doi: 10.1161/CIRCULATIONAHA.123.065394.
    PubMed     Abstract available


  9. RASMUSSEN SB, Jeppesen KK, Kjaergaard J, Hassager C, et al
    Blood Pressure and Oxygen Targets on Kidney Injury After Cardiac Arrest.
    Circulation. 2023;148:1860-1869.
    PubMed     Abstract available


    November 2023
  10. HUNDEMER GL, Agharazii M, Madore F, Vaidya A, et al
    Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
    Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066389.
    PubMed     Abstract available


  11. WALTERS R, Vasilaki E, Wilkins MR, Zhao L, et al
    Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1825-1826.
    PubMed    


  12. LI G, Chen H, Ren C
    Letter by Li et al Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1823-1824.
    PubMed    


  13. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    PubMed    


  14. KITT J, Krasner S, Barr L, Frost A, et al
    Cardiac Remodeling After Hypertensive Pregnancy Following Physician-Optimized Blood Pressure Self-Management: The POP-HT Randomized Clinical Trial Imaging Sub-study.
    Circulation. 2023 Nov 11. doi: 10.1161/CIRCULATIONAHA.123.067597.
    PubMed     Abstract available


    October 2023
  15. AZIZI M, Sharp ASP, Fisher NDL, Weber MA, et al
    Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months Following Medication Escalation: The RADIANCE Clinical Trial Program.
    Circulation. 2023 Oct 26. doi: 10.1161/CIRCULATIONAHA.123.066941.
    PubMed     Abstract available


  16. OSTROMINSKI JW, Vaduganathan M, Selvaraj S, Claggett BL, et al
    Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
    Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065254.
    PubMed     Abstract available


    September 2023
  17. KUEHN BM
    Experimental Drug, Combination Pill Show Promise for Treating Pulmonary Hypertension.
    Circulation. 2023;148:852-854.
    PubMed    


    August 2023
  18. WANG Z, Du X, Hua C, Li W, et al
    The Effect of Frailty on the Efficacy and Safety of Intensive Blood Pressure Control: A Post Hoc Analysis of the SPRINT Trial.
    Circulation. 2023;148:565-574.
    PubMed     Abstract available


    July 2023
  19. NOLDE JM, Atkins E, Marschner S, Hillis GS, et al
    Effect of Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension on Ambulatory Blood Pressure Indices: Results From the QUARTET
    Circulation. 2023;148:375-377.
    PubMed    



  20. Correction to: Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
    Circulation. 2023;148:e2.
    PubMed    


    May 2023
  21. GARDNER CD, Vadiveloo MK, Petersen KS, Anderson CAM, et al
    Popular Dietary Patterns: Alignment With American Heart Association 2021 Dietary Guidance: A Scientific Statement From the American Heart Association.
    Circulation. 2023;147:1715-1730.
    PubMed     Abstract available


  22. JANI V, Aslam MI, Fenwick AJ, Ma W, et al
    Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure With Pulmonary Hypertension.
    Circulation. 2023 May 17. doi: 10.1161/CIRCULATIONAHA.123.064717.
    PubMed     Abstract available



  23. Correction to: Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension.
    Circulation. 2023;147:e718.
    PubMed    


    April 2023
  24. GUIGNABERT C, Savale L, Boucly A, Thuillet R, et al
    Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.
    Circulation. 2023 Apr 25. doi: 10.1161/CIRCULATIONAHA.122.061501.
    PubMed     Abstract available


  25. WALTERS R, Vasilaki E, Aman J, Chen CN, et al
    SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension.
    Circulation. 2023 Apr 17. doi: 10.1161/CIRCULATIONAHA.122.061940.
    PubMed     Abstract available


  26. MITCHELL BD, Whitlatch HB
    Decoding Hypertension Through Primary Aldosteronism.
    Circulation. 2023;147:1110-1111.
    PubMed    


    March 2023
  27. PITT B, Vaidya A
    Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension.
    Circulation. 2023;147:991-992.
    PubMed    


  28. HINKLE SN, Schisterman EF, Liu D, Pollack AZ, et al
    Pregnancy Complications and Long-Term Mortality in a Diverse Cohort.
    Circulation. 2023;147:1014-1025.
    PubMed     Abstract available


  29. RAJAGOPAL S, Ruetzler K, Ghadimi K, Horn EM, et al
    Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Mar 16. doi: 10.1161/CIR.0000000000001136.
    PubMed     Abstract available


    February 2023
  30. NAITO T, Inoue K, Sonehara K, Baba R, et al
    Genetic Risk of Primary Aldosteronism and Its Contribution to Hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide Association Study.
    Circulation. 2023 Feb 21. doi: 10.1161/CIRCULATIONAHA.122.062349.
    PubMed     Abstract available


  31. CHIN KM, Santiago-Munoz P
    Pregnancy and Congenital Heart Disease-Associated Pulmonary Hypertension: Are Outcomes Improving?
    Circulation. 2023;147:562-564.
    PubMed    


  32. BADROV MB, Yoo JK, Hissen SL, D'Souza AW, et al
    Muscle Sympathetic Action Potential Firing Patterns During Normotensive and Hypertensive Pregnancy: A Longitudinal Assessment.
    Circulation. 2023;147:611-613.
    PubMed    


  33. ZHANG Q, Zhu F, Shi G, Hu C, et al
    Maternal Outcomes Among Pregnant Women With Congenital Heart Disease-Associated Pulmonary Hypertension.
    Circulation. 2023;147:549-561.
    PubMed     Abstract available


  34. GRASHOW R, Tan CO, Izzy S, Taylor HA Jr, et al
    Association Between Concussion Burden During Professional American-style Football and Post-career Hypertension.
    Circulation. 2023 Feb 7. doi: 10.1161/CIRCULATIONAHA.122.063767.
    PubMed    


  35. KUEHN BM
    No Benefit Seen for Nighttime Dosing Over Morning Dosing for Antihypertensive Medications.
    Circulation. 2023;147:512-514.
    PubMed    


    January 2023
  36. BERRY JD, Chen H, Nambi V, Ambrosius WT, et al
    Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
    Circulation. 2023;147:310-323.
    PubMed     Abstract available


    December 2022
  37. OBEL LM, Lindholt JS, Lasota AN, Jensen HK, et al
    Clinical Characteristics, Incidences, and Mortality Rates for Type A and B Aortic Dissections: A Nationwide Danish Population-Based Cohort Study From 1996 to 2016.
    Circulation. 2022;146:1903-1917.
    PubMed     Abstract available


  38. BORN E, Lipskaia L, Breau M, Houssaini A, et al
    Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
    Circulation. 2022 Dec 14. doi: 10.1161/CIRCULATIONAHA.122.058794.
    PubMed     Abstract available


    November 2022
  39. AGARWAL R
    Hydrochlorothiazide Versus Chlorthalidone: What Is the Difference?
    Circulation. 2022;146:1641-1643.
    PubMed    


  40. ZHOU W, Liu K, Zeng L, He J, et al
    Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension.
    Circulation. 2022 Nov 17. doi: 10.1161/CIRCULATIONAHA.122.061900.
    PubMed     Abstract available



  41. Correction to: Decoding the Link Between Inflammation and Pulmonary Arterial Hypertension.
    Circulation. 2022;146:e280.
    PubMed    


    October 2022
  42. ERCU M, Mucke MB, Pallien T, Marko L, et al
    Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage.
    Circulation. 2022 Oct 19:101161CIRCULATIONAHA122060210.
    PubMed     Abstract available


    September 2022
  43. BAI C, Su M, Zhang Y, Lin Y, et al
    Oviductal Glycoprotein 1 Promotes Hypertension by Inducing Vascular Remodeling Through an Interaction With MYH9.
    Circulation. 2022 Sep 29:101161CIRCULATIONAHA121057178.
    PubMed     Abstract available



  44. Correction to: Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
    Circulation. 2022;146:e168.
    PubMed    


  45. VIDAL-PETIOT E
    Thresholds for Hypertension Definition, Treatment Initiation, and Treatment Targets: Recent Guidelines at a Glance.
    Circulation. 2022;146:805-807.
    PubMed    


  46. GOTO S, Solanki D, John JE, Yagi R, et al
    Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection.
    Circulation. 2022;146:755-769.
    PubMed     Abstract available


    August 2022
  47. AGARWAL R, Sinha AD, Tu W
    Chlorthalidone for Resistant Hypertension in Advanced Chronic Kidney Disease.
    Circulation. 2022;146:718-720.
    PubMed    


  48. CAO N, Lan C, Chen C, Xu Z, et al
    Prenatal Lipopolysaccharides Exposure Induces Transgenerational Inheritance of Hypertension.
    Circulation. 2022 Aug 25:CIRCULATIONAHA122059891.
    PubMed     Abstract available


  49. BRUSCA SB, Elinoff JM, Zou Y, Jang MK, et al
    Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.
    Circulation. 2022 Aug 25:101161CIRCULATIONAHA121056719.
    PubMed     Abstract available


  50. YAKU A, Inagaki T, Asano R, Okazawa M, et al
    Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Circulation. 2022 Aug 23:101161CIRCULATIONAHA122059435.
    PubMed     Abstract available


  51. RUFFENACH G, Medzikovic L, Aryan L, Li M, et al
    HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension.
    Circulation. 2022 Aug 22:101161CIRCULATIONAHA122059591.
    PubMed     Abstract available


  52. TOUYZ RM
    TRPV4 Channel-Regulated Microdomains Define a New Paradigm in Hypertension.
    Circulation. 2022;146:565-568.
    PubMed    


  53. CHEN YL, Daneva Z, Kuppusamy M, Ottolini M, et al
    Novel Smooth Muscle Ca(2+)-Signaling Nanodomains in Blood Pressure Regulation.
    Circulation. 2022;146:548-564.
    PubMed     Abstract available


  54. WHELTON PK, Carey RM, Mancia G, Kreutz R, et al
    Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations.
    Circulation. 2022 Aug 11:101161CIRCULATIONAHA121054602.
    PubMed     Abstract available


  55. WELLS CE, Cunningham FG
    Treatment of Chronic Hypertension in Pregnancy: Is It Time for a Change?
    Circulation. 2022;146:433-434.
    PubMed    


    July 2022
  56. WANG Y, Feng L, Zeng G, Zhu H, et al
    Effects of Cuisine-Based Chinese Heart-Healthy Diet in Lowering Blood Pressure Among Adults in China: Multicenter, Single-Blind, Randomized, Parallel Controlled Feeding Trial.
    Circulation. 2022;146:303-315.
    PubMed     Abstract available


  57. BRITTAIN EL, Thenappan T, Huston JH, Agrawal V, et al
    Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.
    Circulation. 2022 Jul 11:101161CIR0000000000001079.
    PubMed     Abstract available


  58. TREMBLAY E, Gosselin C, Mai V, Lajoie AC, et al
    Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Circulation. 2022 Jul 8:101161CIRCULATIONAHA121058635.
    PubMed     Abstract available


    May 2022
  59. BROOK RD, Scirica BM, Levy PD
    "The Doctor Is Out": New Tactics and Soldiers for Our Losing Battle Against Hypertension.
    Circulation. 2022;145:1629-1631.
    PubMed    


    March 2022
  60. LI KC, Huang L, Tian M, Di Tanna GL, et al
    Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS).
    Circulation. 2022 Mar 21. doi: 10.1161/CIRCULATIONAHA.122.059573.
    PubMed     Abstract available


  61. STEWART RH, Cox CS Jr, Allen SJ, Laine GA, et al
    Myocardial Edema Provides a Link Between Pulmonary Arterial Hypertension and Pericardial Effusion.
    Circulation. 2022;145:793-795.
    PubMed    


  62. KANDZARI DE, Mahfoud F, Weber MA, Townsend R, et al
    Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.
    Circulation. 2022;145:847-863.
    PubMed     Abstract available


  63. LECHUGA-VIECO AV, Latorre-Pellicer A, Calvo E, Torroja C, et al
    Heteroplasmy of Wild Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
    Circulation. 2022 Mar 3. doi: 10.1161/CIRCULATIONAHA.121.056286.
    PubMed     Abstract available


  64. NIENABER CA, Yuan X
    Taming Hypertension to Prevent Aortic Dissection: Universal Recognition of a "New Normal" Blood Pressure?
    Circulation. 2022;145:645-647.
    PubMed    


    February 2022
  65. VEITH C, Varturk-Ozcan I, Wujak M, Hadzic S, et al
    Secreted Protein Acidic and Rich in Cysteine, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
    Circulation. 2022 Feb 17. doi: 10.1161/CIRCULATIONAHA.121.057001.
    PubMed     Abstract available


  66. HONIGBERG MC, Zekavat SM, Raghu VK, Natarajan P, et al
    Microvascular Outcomes in Women With a History of Hypertension in Pregnancy.
    Circulation. 2022;145:552-554.
    PubMed    


  67. MACINTYRE IM, Turtle EJ, Farrah TE, Graham C, et al
    Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial.
    Circulation. 2022;145:416-423.
    PubMed     Abstract available


  68. SMITH SM, Cooper-DeHoff RM
    Acetaminophen-Induced Hypertension: Where Have All the "Safe" Analgesics Gone?
    Circulation. 2022;145:424-426.
    PubMed    


    January 2022
  69. LAFFIN LJ, Kaufman HW, Chen Z, Niles JK, et al
    Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic.
    Circulation. 2022;145:235-237.
    PubMed    


    November 2021

  70. Correction to: National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).
    Circulation. 2021;144:e333.
    PubMed    


  71. NAEIJE R
    Letter by Naeije Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Circulation. 2021;144:e328-e329.
    PubMed    


  72. HOWDEN EJ, Ruiz-Carmona S, La Gerche A, Delcroix M, et al
    Response by Howden et al to Letter Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Circulation. 2021;144:e330-e331.
    PubMed    


  73. HIBINO M, Otaki Y, Kobeissi E, Pan H, et al
    Blood Pressure, Hypertension and The Risk of Aortic Dissection Incidence and Mortality: results from the Japan-Specific Health Checkups Study, the UK Biobank Study and a Meta-analysis of Cohort Studies.
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.056546.
    PubMed     Abstract available


  74. LU Y, Wang Y, Spatz ES, Onuma O, et al
    National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.057056.
    PubMed    


    October 2021
  75. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    PubMed     Abstract available


  76. WEI J, Fang D
    Letter by Wei and Fang Regarding Article, "Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies".
    Circulation. 2021;144:e236.
    PubMed    


  77. FILIPPINI T, Malavolti M, Whelton PK, Naska A, et al
    Response by Filippini et al to Letter Regarding Article, "Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies".
    Circulation. 2021;144:e237.
    PubMed    


    September 2021
  78. BLUMENTHAL JA, Hinderliter AL, Smith PJ, Mabe S, et al
    Effects of Lifestyle Modification on Patients With Resistant Hypertension: Results of the TRIUMPH Randomized Clinical Trial.
    Circulation. 2021 Sep 27. doi: 10.1161/CIRCULATIONAHA.121.055329.
    PubMed    


  79. LEO F, Suvorava T, Heuser SK, Li J, et al
    Red Blood Cell and Endothelial eNOS Independently Regulate Circulating Nitric Oxide Metabolites and Blood Pressure.
    Circulation. 2021;144:870-889.
    PubMed     Abstract available


    August 2021
  80. LEOPOLD JA
    Nanoparticle-Facilitated Gene Delivery in Congenital Pulmonary Vascular Disease: Roadmap for Other Forms of Pulmonary Hypertension.
    Circulation. 2021;144:556-558.
    PubMed    


    July 2021
  81. QI H, Liu H, Pullamsetti SS, Gunther S, et al
    Epigenetic Regulation by Suv4-20h1 in Cardiopulmonary Progenitor Cells is Required to Prevent Pulmonary Hypertension and COPD.
    Circulation. 2021 Jul 12. doi: 10.1161/CIRCULATIONAHA.120.051680.
    PubMed     Abstract available


    June 2021
  82. SATOH T, Wang L, Espinosa-Diez C, Wang B, et al
    Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Down Regulation of sGC and Contributes to Exercise-Induced Pulmonary Hypertension in HFpEF.
    Circulation. 2021 Jun 23. doi: 10.1161/CIRCULATIONAHA.121.053889.
    PubMed     Abstract available


  83. RAYNER BL, Spence JD
    Physiological Treatment of Hypertension in Black Patients: Time for Action.
    Circulation. 2021;143:2367-2369.
    PubMed    


  84. KAZI DS, Wei PC, Penko J, Bellows BK, et al
    Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value.
    Circulation. 2021;143:2406-2408.
    PubMed    


  85. JOSEPH JJ, Pohlman NK, Zhao S, Kline D, et al
    Association of Serum Aldosterone and Plasma Renin Activity With Ambulatory Blood Pressure in African Americans: The Jackson Heart Study.
    Circulation. 2021;143:2355-2366.
    PubMed     Abstract available


  86. SUN F, Wang G, Pradhan A, Xu K, et al
    Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
    Circulation. 2021 Jun 11. doi: 10.1161/CIRCULATIONAHA.121.053980.
    PubMed     Abstract available


  87. BISSERIER M, Mathiyalagan P, Zhang S, Elmastour F, et al
    Regulation of The Methylation and Expression Levels of the BMPR2 Gene by SIN3a As A Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.
    Circulation. 2021 Jun 3. doi: 10.1161/CIRCULATIONAHA.120.047978.
    PubMed     Abstract available


    May 2021
  88. KARIO K, Kanegae H, Hoshide S
    Response by Kario et al to Letter Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e982-e983.
    PubMed    


  89. PENGO MF, Bisogni V, Martinez-Garcia MA
    Letter by Pengo et al Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e980-e981.
    PubMed    


  90. BROOK RD, Levy PD, Jamerson KA
    Mission "UnACCOMPLISHed": Optimal Antihypertensive Therapy.
    Circulation. 2021;143:1932-1934.
    PubMed    


  91. KARIO K, Ferdinand KC, Vongpatanasin W
    Are SGLT2 Inhibitors New Hypertension Drugs?
    Circulation. 2021;143:1750-1753.
    PubMed    


    April 2021
  92. KANEKO H, Yano Y, Itoh H, Morita K, et al
    Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.
    Circulation. 2021 Apr 22. doi: 10.1161/CIRCULATIONAHA.120.052624.
    PubMed     Abstract available


  93. FILIPPINI T, Malavolti M, Whelton PK, Naska A, et al
    Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies.
    Circulation. 2021;143:1542-1567.
    PubMed     Abstract available


  94. BRYANT KB, Moran AE, Kazi DS, Zhang Y, et al
    Cost-effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.051683.
    PubMed     Abstract available


  95. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
    Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
    PubMed     Abstract available


    November 2020
  96. KARIO K, Hoshide S, Mizuno H, Kabutoya T, et al
    Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
    Circulation. 2020 Nov 2. doi: 10.1161/CIRCULATIONAHA.120.049730.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.